Introduction
============

Understanding the spatio-temporal patterns of neuronal activity underlying brain function is one of the fundamental goals in neuroscience research, and requires techniques for the large-scale recording in living animals. The repertoire of *in vivo* multi-cell recording techniques has been enriched by the recent establishment of *in vivo* Ca^2+^ imaging, a combination of multi-photon imaging and bolus loading of synthetic Ca^2+^ dyes (Stosiek et al., [@B44]). *In vivo* Ca^2+^ imaging allows not only multi-cell recording based on fast Ca^2+^ transients generated by action potentials (APs; Markram et al., [@B29]; Schiller et al., [@B42]; Helmchen et al., [@B12]), but also the precise localization of recorded cells. It has thus contributed to unveiling the functional micro-architecture of many brain regions (Ohki et al., [@B35], [@B36]; Kerr et al., [@B19], [@B18]; Sullivan et al., [@B45]; Rothschild et al., [@B41]; Smith and Häusser, [@B43]), which was difficult to achieve using classical electrode-based techniques. However, the lack of cell type specificity, the unrepeatability, and the short-lived nature (typically less than 1 day) of imaging using synthetic Ca^2+^ dyes has remained an obstacle for further applications.

Genetically encoded Ca^2+^ indicators (GECIs; for review, Miyawaki, [@B32]; Mank and Griesbeck, [@B25]), which are Ca^2+^-sensitive fluorescent proteins (FPs), can in principle offer an excellent solution to these problems, since they can be stably and specifically expressed in a targeted cell type by the use of appropriate promoters and transfection methods. \[Ca^2+^\]~i~ changes cause structural changes of the Ca^2+^-sensing domains in GECIs, which further cause changes in either (1) fluorescence resonance energy transfer (FRET) efficiency between two FPs or (2) the fluorescent intensity of a single circularly permutated (cp) FP, depending on the design of GECIs. GECIs have been successfully applied in many model organisms including *Caenorhabditis elegans* (Kerr et al., [@B20]), *Drosophila melanogaster* (Fiala et al., [@B6]), and *Danio rerio* (Higashijima et al., [@B14]), where electrode penetration and exogenous dye application are technically challenging. In the mammalian central nervous system (CNS), initial attempts using prototypical GECIs were somewhat disappointing (Hasan et al., [@B8]; Pologruto et al., [@B40]), but recently developed GECIs have been shown to display improved performance (Heim et al., [@B11]; Mank et al., [@B26]; Wallace et al., [@B48]; Tian et al., [@B47]; Horikawa et al., [@B16]; Lütcke et al., [@B23]) and have been used to address biologically relevant questions (e.g., Dombeck et al., [@B5]). Nevertheless, most applications of GECIs in the mammalian CNS have been limited to cortical and hippocampal pyramidal cells, and how GECIs perform in other cell types has remained largely unknown. There are a few exceptions where GCaMP2 has been tested in cerebellar granule cells as well as Purkinje cells (Díez-García et al., [@B4], [@B3]; Akemann et al., [@B1]), but the relationship between fluorescent changes and intracellular electrical responses of imaged cells was not investigated, nor was the performance of multiple GECIs compared under the same experimental conditions. The application of novel GECIs to broader contexts should be facilitated by quantitative comparison of their performance in reference to intracellular electrical signals.

In the present study, we selected the latest series of FRET-based GECIs (Figure [1](#F1){ref-type="fig"}A): yellow cameleon (YC) 2.60, YC3.60 (Nagai et al., [@B34]), YC-Nano15 (Horikawa et al., [@B16]), and the latest cpGFP-based GECI, GCaMP3 (Tian et al., [@B47]). We expressed each of them in mouse cortical pyramidal cells as well as in cerebellar Purkinje cells by *in utero* injection of recombinant adenoviral vectors (Hashimoto and Mikoshiba, [@B9], [@B10]). All the YCs above utilize calmodulin (CaM) and M13 (Ca^2+^/CaM-binding peptide derived from skeletal muscle myosin light chain kinase) as Ca^2+^-sensing domain, but their *in vitro* affinities are modified by molecular engineering: YC3.60 carries a mutation in EF-hand motif of CaM (E104Q) resulting in a larger dissociation constant (*K*~d~) value (\~250 nM) than that of YC2.60 (\~95 nM), while YC-Nano15 has an elongated linker between CaM and M13 (GGGGS) than that used in YC2.60 and YC3.60 (GGS), resulting in an extremely smaller *K*~d~ value (\~15 nM). GCaMP3, which also utilizes CaM and M13 as Ca^2+^-sensing domain, was constructed by mutagenesis of GCaMP2, resulting in slightly lower *K*~d~ value (660 nM; GCaMP2, 840 nM), improved baseline brightness, and expanded dynamic range. Using simultaneous patch-clamp recording and two-photon imaging in acute brain slices at physiologically relevant temperatures (33 ± 2°C), we characterized the performance of these GECIs, and investigated which GECIs could be optimal for applications in each cell type.

![**Adenovirus-mediated expression of GECIs**. **(A)** The domain structure of GECIs. ECFPΔC11, enhanced CFP with C-terminal 11 amino acids deleted; CaM, calmodulin; M13, Ca^2+^/CaM-binding peptide from skeletal muscle myosin light chain kinase; cp173Venus, circularly permuted Venus; cpEGFP, circularly permutated enhanced green fluorescent protein. **(B)** The structure of recombinant adenovirus vector for expression of GECIs. CAG pro, cytomegalovirus enhancer and β-actin promoter; WPRE, woodchuck hepatitis virus post-transcriptional regulatory element; BGHpA, bovine growth hormone polyadenylation signal. **(C)** Confocal image of a parasagittal section from an E14:P20 YC2.60 mouse. Each cortical layer (L) position is indicated in white. **(D)** Confocal image of the neocortex immunostained with anti-CaMKII antibody, a marker for excitatory pyramidal cells. **(E)** Confocal image of a parasagittal section from an E11:P21 YC2.60 mouse. ML, molecular layer; GCL, granule cell layer. **(F)** Confocal image of the cerebellum immunostained with anti-IP~3~R1 antibody, a marker for Purkinje cells.](fncel-05-00018-g001){#F1}

Materials and Methods
=====================

All experimental procedures were performed in accordance with the guidelines of the Animal Experiment Committee of the RIKEN Brain Science Institute and with the UK Animal (Scientific Procedures) Act 1986.

Expression of GECIs
-------------------

cDNAs encoding YC2.60, YC3.60, YC-Nano15, and GCaMP3 (Figure [1](#F1){ref-type="fig"}A) were subcloned into a cosmid vector carrying the cytomegalovirus enhancer and β-actin (CAG) promoter, woodchuck hepatitis virus post-transcriptional regulatory element (WPRE), and bovine growth hormone (BGH) polyadenylation signal (Figure [1](#F1){ref-type="fig"}B). Recombinant adenovirus was generated either by full-length DNA transfer method (Takara) or by COS--TPC method (Miyake et al., [@B31]) using HEK293 cells (kindly provided by the Cell Resource Center for Biomedical Research, Institute of Development, Aging and Cancer, Tohoku University). Viral clones were screened by restriction mapping of their genomic DNA, and appropriate clones were amplified and then purified by double cesium chloride step gradient ultracentrifugation (Kanegae et al., [@B17]). The titer of purified virus was measured by plaque forming assay with HEK293 cells. Purified viral solution (total 0.2 to 6 × 10^7^ plaque forming units) was pressure-injected (IM-300, Narishige) into the lateral ventricle of ICR mice on embryonic day (E) 11 or E12 for expression in cerebellar Purkinje cells or E14 for cortical layer 2/3 pyramidal cells, respectively. In the following, a mouse virus-injected at E14 and sacrificed at P20, for instance, is described as "E14:P20."

Immunohistochemistry
--------------------

Mice were transcardially perfused with phosphate buffer saline (PBS) followed by 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) under ether anesthesia. The brain was dissected out, cryoprotected by serial equilibration in 10, 15, and 20% (w/v) sucrose in PBS at 4°C and frozen in O.C.T compound (Sakura Fineteh). Parasagittal sections (14--20 μm) were prepared on a cryostat (CM1850, Leica), attached to MAS-coated glass slides (Matsunami) and subjected to immunohistochemistry as follows. Cryosections were washed three times with PBS, blocked with 10% normal goat serum (NGS) in PBS containing 0.2% TritonX-100 (PBS-T) for 1 h at room temperature, incubated with primary antibodies diluted by 1% NGS in PBS-T overnight at 4°C, washed three times with PBS, incubated with species-specific secondary antibodies (anti-rabbit or anti-mouse IgG) conjugated with Alexa-488 or 594 (Invitrogen) diluted by 1% NGS in PBS-T (1:500) for 1 h at room temperature and washed three times with PBS. The sections were then coverslipped with VECTASHIELD (Vector) or ProLong Gold (Invitrogen).

The primary antibodies used were as follows: anti-GFP (rabbit, 1:1000; mouse, 1:200, both from MBL), anti-calcium/calmodulin-dependent protein kinase (CaMKII; rabbit, 1:500, Epitomics), and anti-inositol 1,4,5-triphosphate receptor type1 (IP~3~R1; mouse, 1:1000, generated in our laboratory). The sections were imaged by an inverted confocal laser-scanning microscope (IX-81 and FV-1000, Olympus) equipped with a 10 × (UPlanApo NA 0.40, Olympus) or 40 × objective (UPlanApo NA 1.00, Olympus). Alexa-488 was excited by 473 nm laser and its emission between 490 and 550 nm was collected; Alexa-594 was excited by 559 nm laser and its emission between 600 and 700 nm was collected.

Electrophysiology and two-photon imaging in acute brain slice
-------------------------------------------------------------

Mice were decapitated under ether anesthesia, and parasagittal slices (250--300 μm) were prepared using a vibratome (VT1000S, Leica) on postnatal day (P) 15--57 (except data in Figure [4](#F4){ref-type="fig"}; Table [5](#T5){ref-type="table"}, where mice between P113 and 114 were used), as described previously (Davie et al., [@B2]). Brain dissection and slice preparation were performed in ice-cold cutting solution containing 120 mM Choline-Cl, 3 mM KCl, 8 mM MgCl~2~, 1.25 mM NaH~2~PO~4~, 26 mM NaHCO~3~, 20 mM [d]{.smallcaps}-glucose, and transferred to artificial cerebral spinal fluid (ACSF) containing 125 mM NaCl, 2.5 mM KCl, 25 mM NaHCO~3~, 25 mM [d]{.smallcaps}-glucose, 1.25 mM NaH~2~PO~4~, 2 mM CaCl~2~, and 1 mM MgCl~2~, incubated at 34°C for 30--60 min and preserved at room temperature until use. Slices were perfused at approximately 2 ml/min with ACSF, which was constantly bubbled with carbogen and warmed up to 33 ± 2°C by an in-line heater (TC-324B, Warner Instruments). GECI-expressing cells with non-fluorescent nuclei (Tian et al., [@B47]) were identified by epifluorescence and targeted for patch-clamp recording under infra-red differential interference contrast microscopy (Olympus). Electrophysiological signals were low-pass filtered at 2--10 kHz by four-pole Bessel filter and acquired at 20--50 kHz using a combination of MultiClamp 700B (Molecular Devices) and ITC-16 or ITC-18 (Instrutech) controlled by AxoGraphX software (AxoGraph Scientific). For whole-cell current-clamp recording, borosilicate glass pipettes (4--7 MΩ) were filled with the internal solution containing 140 mM K-gluconate, 4 mM NaCl, 10 mM HEPES, 4 mM Mg-ATP, 0.3 mM Na-GTP, and 5 mM Na~2~-phosphocreatine (pH 7.3 titrated with KOH, 285--295 mmol/kg). APs were elicited by brief somatic current pulses (1--3 nA, 2 ms) delivered through recording patch pipettes. Synaptic responses were elicited by extracellular electrical stimulation (1--50 V, 200 μs) by pipettes filled with the HEPES-buffered solution containing 150 mM NaCl, 2.5 mM KCl, 10 mM HEPES, 2 mM CaCl~2~, 1 mM MgCl~2~ (pH 7.3 titrated with NaOH). For pyramidal cell recording, no holding current was injected; for Purkinje cell recording, holding current up to −500 pA was injected to suppress spontaneous firing.

Fluorescent signals were acquired in line-scan mode (approximately 200 Hz) with an upright two-photon laser-scanning microscope (BX-61WI and FV300, Olympus) equipped with a 60 × water-immersion objective (LUMPlan Fl/IR NA 0.90, Olympus). The Ti:sapphire laser (Maitai VF-TIM, Spectra-Physics) for excitation was tuned to 840 nm for YCs or 920 nm for GCaMP. Emitted fluorescence was short-pass filtered (650 nm, Olympus), split with a dichroic mirror (for YC, 510 nm, Chroma; for GCaMP3, 570 nm, Olympus), band-pass filtered (for YC, 460--500 and 520--550 nm for cyan and yellow fluorescence, respectively, Chroma; for GCaMP3, 495--540 nm, Olympus), and detected by photomultipliers (R3896, Hamamatsu).

The electrophysiological recording and two-photon imaging were synchronized by a trigger pulse generated upon laser-scanning.

Data analysis
-------------

After subtraction of dark noise on the photomultipliers, the baseline ratio of yellow to cyan fluorescence (R~0~, YCs) or baseline fluorescence (F~0~, GCaMP3) was calculated as the mean ratio or mean fluorescence, respectively, of the approximately 1-s window immediately before stimulus onset (baseline period). Subsequently, the fractional change of the ratio (ΔR/R~0~, YCs) or the fractional change of the fluorescence (ΔF/F~0~, GCaMP3) was calculated. Peak amplitude was calculated from ΔR/R~0~ or ΔF/F~0~ trace filtered with a 35-ms moving window and defined as the maximum value between the stimulus onset and 500 ms after the stimulus cessation. The signal-to-noise ratio (SNR) was calculated as the peak amplitude divided by the baseline noise (the SD of the raw trace during the baseline period). Both peak amplitude and SNR were calculated from individual trials and averaged over three trials for each stimulus condition (Table [2](#T2){ref-type="table"}, [4](#T4){ref-type="table"}, and [5](#T5){ref-type="table"}). Responses were judged to be suprathreshold when SNR exceeds 2. Half rise time and half decay time were calculated from the 3-trial-averaged and filtered traces for 10 APs (pyramidal cells) or 5 complex spikes (CSs; Purkinje cells) only when responses were suprathreshold. Statistical difference was assessed using one-way ANOVA (*p* = 0.05) followed by Tukey's post-hoc tests unless otherwise noted. Data analysis was performed with AxoGraphX, Igor Pro 6 (WaveMetrics), NeuroMatic (<http://www.neuromatic.thinkrandom.com/>), Fluoview (Olympus), ImageJ (US National Institutes of Health), Excel (Microsoft), and GraphPad Prism4 (GraphPad software). All values are presented as mean ± SD unless otherwise noted.

Results
=======

Adenovirus-mediated expression of GECIs in cortical pyramidal cells and cerebellar Purkinje cells
-------------------------------------------------------------------------------------------------

In order to express GECIs in the mouse brain, we performed *in utero* injection of adenoviral vectors (Hashimoto and Mikoshiba, [@B9], [@B10]). This allows "neuronal birthday-specific" introduction of a foreign gene, since adenoviral infection is temporarily short (up to 4 h) and the adenoviral gene is transferred exclusively to the neuronally committed-daughter cells divided from stem cells on the ventricular surface of embryonic brain. We previously used LacZ-carrying adenovirus and demonstrated that injection at E14 led to expression in cortical superficial layer and that injection at E11 or E12 led to expression in cortical deep layer as well as cerebellar Purkinje cells. We performed immunohistochemical analysis to test if this specific expression pattern is reproducible with adenoviral vectors carrying GECIs (Figure [1](#F1){ref-type="fig"}). The injection of YC2.60-carrying adenovirus at E14 resulted in expression in the superficial layer of neocortex (Figure [1](#F1){ref-type="fig"}C). The majority (97%; *n* = 119 of 123 cells) of expressing cells were immunopositive for CaMKII (Figure [1](#F1){ref-type="fig"}D), indicating that they were pyramidal cells. The injection of YC2.60-carrying adenovirus at E11 or E12 resulted in expression in cortical deep layer (data not shown) as well as cerebellum (Figure [1](#F1){ref-type="fig"}E). All (*n* = 76 of 76 cells) of the expressing cells in cerebellum were immunopositive for IP~3~R1, indicating that they were Purkinje cells. These results show that *in utero* injection of recombinant adenoviral vectors carrying GECIs could lead to their specific expression in cortical pyramidal cells as well as cerebellar Purkinje cells, successfully reproducing our previous results.

Comparison of GECIs in cortical layer 2/3 pyramidal cells
---------------------------------------------------------

We characterized the performance of GECIs expressed in the cortical layer 2/3 pyramidal cells by simultaneous two-photon imaging and whole-cell patch-clamp recording in acute brain slice preparations (Figure [2](#F2){ref-type="fig"}A). The expression of GECIs did not have any significant effects on the electrophysiological properties of pyramidal cells (Table [1](#T1){ref-type="table"}). We evoked APs by somatic current injection and recorded fluorescent changes by line-scan imaging at apical dendritic segments (Figures [2](#F2){ref-type="fig"}B,C). Responses to 1, 2, 5, 10, and 20 APs at 20 Hz were analyzed (Figures [2](#F2){ref-type="fig"}D,E; Table [2](#T2){ref-type="table"}). In response to single APs, YC2.60 as well as YC-Nano15 showed signal changes well over the threshold (SNR = 2), YC3.60 showed barely suprathreshold changes, but GCaMP3 did not; YC2.60 showed the largest SNR among all, and YC-Nano15 showed significantly larger SNR than GCaMP3 (Figure [2](#F2){ref-type="fig"}F; Table [2](#T2){ref-type="table"}; YC2.60, 4.3 ± 1.7, *n* = 19; YC3.60, 2.1 ± 0.4, *n* = 11; YC-Nano15, 3.1 ± 1.0, *n* = 14; GCaMP3, 1.3 ± 0.6, *n* = 7). Responses to single APs were suprathreshold in 89% (*n* = 17 of 19) of YC2.60-expressing cells and 93% (*n* = 13 of 14) of YC-Nano15-expressing cells, but only in 55% (*n* = 6 of 11) of YC3.60-expressing cells and 14% (*n* = 1 of 7) of GCaMP3-expressing cells. YC2.60, YC3.60, and GCaMP3 showed nearly linear increase of SNR up to 20 APs in majority of cells, while YC-Nano15 showed signal saturation to a large number of APs, as expected from its extremely high affinity to Ca^2+^ (Figures [2](#F2){ref-type="fig"}D,E). In response to 20 APs, GCaMP3 showed the largest SNR among all (YC2.60, 23 ± 12, *n* = 10; YC3.60, 19 ± 2.3, *n* = 8; YC-Nano15, 8.0 ± 3.9, *n* = 7; GCaMP3, 41 ± 15, *n* = 6). Half rise time values (Figure [2](#F2){ref-type="fig"}G) of YC2.60 (185 ± 55 ms, *n* = 10) and YC-Nano15 (159 ± 28 ms, *n* = 7) were significantly smaller than those of YC3.60 (214 ± 28 ms, *n* = 8) and GCaMP3 (288 ± 18 ms, *n* = 6), whereas half decay time values (Figure [2](#F2){ref-type="fig"}H) of YC2.60 (2.31 ± 0.95 s, *n* = 10) and YC-Nano15 (2.38 ± 0.92 s, *n* = 7) were significantly larger than those of YC3.60 (0.40 ± 0.06 s, *n* = 8) and GCaMP3 (0.22 ± 0.06 s, *n* = 6).

![**Quantitative comparison of GECIs in cortical layer 2/3 pyramidal cells**. **(A)** Maximum intensity projection images of an E14:P19 YC2.60-expressing pyramidal cells (left), and expanded single *z*-section images within the white boxes (right). A patch pipette is drawn with dotted lines. Line-scan imaging was performed along the proximal apical dendrite as indicated by the red line. **(B)** Line-scan images of a YC2.60-expressing pyramidal cell in response to 20 action potentials (APs) at 20 Hz evoked during the period indicated. Vertical scale bar, 5 μm. **(C)** Traces calculated from line-scan images in **(B)** were averaged across three trials and smoothed by 35 ms moving window. ΔR/R~0~, FRET signal change; *V*~m~, membrane potential. The scale bar in *V*~m~ inset, 200 ms. **(D)** ΔR/R~0~ (YC) or ΔF/F~0~ (GC3) traces in response to 1 (black), 2 (blue), 5 (green), 10 (orange), and 20 (red) APs evoked at 20 Hz. Each trace is the mean across cells (*n* = 10 cells for YC2.60, 8 for YC3.60, 7 for YC-Nano15, and 6 for GCaMP3). **(E)** Signal-to-noise ratio (SNR) plotted against the number of APs, calculated for individual pyramidal cells (gray) and the mean across cells (black). For 1 AP, *n* = 19 for YC2.60, *n* = 11 for YC3.60, *n* = 14 for YC-Nano15 and *n* = 7 for GCaMP3; For 2, 5, 10, and 20 APs, *n* = 10 for YC2.60, *n* = 8 for YC3.60, *n* = 7 for YC-Nano15, and *n* = 6 for GCaMP3. **(F)** SNR in response to single APs taken from **(E)**. Each dot represents a value taken from an individual cell, and the bar represents the mean across cells. **(G,H)** Mean half rise time **(G)** and mean half decay time **(H)** of smoothed trial-averaged traces in response to 10 APs at 20 Hz. Error bars show SD. \**p* \< 0.05, \*\**p* \< 0.01 in Tukey's post-hoc test following one-way ANOVA.](fncel-05-00018-g002){#F2}

###### 

**Electrophysiological properties of layer 2/3 pyramidal cells expressing GECIs**.

  Electrophysiological property                    YC2.60 (*n* = 22)   YC3.60 (*n* = 16)   YC-Nano15 (*n* = 14)   GCaMP3 (*n* = 7)   no expression (*n* = 11)   *p*-value   
  ------------------------------------------------ ------------------- ------------------- ---------------------- ------------------ -------------------------- ----------- -------
  *V*~m~[^a^](#tfn1){ref-type="table-fn"}          (mV)                −83 ± 5.4           −82 ± 7.4              −81 ± 6.5          −89 ± 4.1                  −82 ± 8.7   0.14
  *R*~m~[^b^](#tfn2){ref-type="table-fn"}          (MΩ)                203 ± 78            191 ± 53               209 ± 59           208 ± 81                   139 ± 42    0.061
  AP amplitude[^c^](#tfn3){ref-type="table-fn"}    (mV)                105 ± 10            98 ± 12                100 ± 6.8          108 ± 8.2                  107 ± 19    0.18
  AP threshold[^d^](#tfn4){ref-type="table-fn"}    (mV)                −47 ± 3.3           −45 ± 5.4              −46 ± 5.4          −50 ± 3.1                  −47 ± 7.4   0.37
  AP half width[^e^](#tfn5){ref-type="table-fn"}   (ms)                2.3 ± 0.8           2.7 ± 1.7              2.5 ± 0.6          1.6 ± 0.5                  1.7 ± 0.5   0.055

*All values are corrected for liquid junction potential (12 mV)*.

*^a^Resting membrane potential*.

*^b^Input resistance*.

*^c^Amplitude of action potential measured from the resting membrane potential*.

*^d^Threshold voltage for action potential generation defined as the point where the first temporal derivative of the voltage first exceeds 50 mV/ms*.

*^e^Full width of action potential measured at half the amplitude*.

###### 

**Responses of GECIs in cortical layer 2/3 pyramidal cells**.

  Number of action potentials   YC2.60 (A; *n* = 10)   YC3.60 (B; *n* = 8)     YC-Nano15 (C; *n* = 7)   GCaMP3 (D; *n* = 6)     ANOVA for SNR
  ----------------------------- ---------------------- ----------------------- ------------------------ ----------------------- --------------------------------------
  1                             4.3 ± 1.7 (18 ± 11)    2.1 ± 0.4 (7.3 ± 2.2)   3.1 ± 1.0 (14 ± 4.2)     1.3 ± 0.6 (5.2 ± 1.9)   *p* \< 0.0001 / A \> B, C, D; C \> D
  2                             7.3 ± 3.9 (34 ± 20)    3.3 ± 0.5 (12 ± 4.2)    3.9 ± 0.8 (19 ± 4.1)     2.6 ± 0.7 (8.6 ± 1.8)   *p* = 0.0011 / A \> B, C, D
  5                             12 ± 6.4 (58 ± 32)     6.9 ± 0.9 (27 ± 10)     6.1 ± 1.9 (28 ± 8.0)     9.2 ± 3.7 (32 ± 12)     *p* = 0.027 / A \> C
  10                            17 ± 10 (82 ± 48)      12 ± 1.4 (49 ± 17)      7.2 ± 3.2 (34 ± 12)      23 ± 9.1 (84 ± 36)      *p* = 0.0041 / D \> C
  20                            23 ± 12 (113 ± 56)     19 ± 2.3 (77 ± 25)      8.0 ± 3.9 (39 ± 15)      41 ± 15 (142 ± 63)      *p* \< 0.0001 / A \> C; D \> A, B, C

*Signal-to-noise ratio and peak amplitude in each stimulus condition; the former in each stimulus condition was statistically compared among GECIs. The numbers of recorded cells in the table apply to 2, 5, 10, and 20 APs; for 1 AP, *n* = 19 for YC2.60, *n* = 11 for YC3.60, *n* = 14 for YC-Nano15, and *n* = 7 for GCaMP3. In the rightmost corner, the combinations that showed significant differences in Tukey's post-hoc tests (*p* \< 0.05) are presented following *p*-value of ANOVA*.

These results show that in cortical pyramidal cells, YC2.60 would be suitable for reliable detection of sparse firing of APs, while GCaMP3 would be suitable for detecting large number of APs due to its large SNR and fast signal decay.

Comparison of GECIs in cerebellar purkinje cells
------------------------------------------------

We next characterized the performance of GECIs expressed in cerebellar Purkinje cells by simultaneous two-photon imaging and whole-cell patch-clamp recording in acute brain slice preparations (Figure [3](#F3){ref-type="fig"}A). The expression of GECIs did not have any significant effects on the electrophysiological properties of Purkinje cells (Table [3](#T3){ref-type="table"}). Since Purkinje cells generate very small amplitude of Ca^2+^ transients in response to simple spikes upon somatic current injection (Lev-Ram et al., [@B22]), we evoked CSs to examine the performance of GECIs in Purkinje cells. CSs were evoked by extracellular stimulation in the granule cell layer and fluorescent changes were recorded by line-scan imaging of distal dendritic segments (Figures [3](#F3){ref-type="fig"}A,B), where maximal Ca^2+^ changes were previously reported (Konnerth et al., [@B21]; Miyakawa et al., [@B30]). Responses to 1, 2, 5, and 10 CSs at 10 Hz were analyzed (Figures [3](#F3){ref-type="fig"}C,D; Table [4](#T4){ref-type="table"}). In response to single CSs, YC2.60, and YC-Nano15 showed suprathreshold signal changes, whereas YC3.60 and GCaMP3 did not; SNR of YC2.60 and YC-Nano15 were significantly larger than those of YC3.60 and GCaMP3 (Figure [3](#F3){ref-type="fig"}E; Table [4](#T4){ref-type="table"}; YC2.60, 2.3 ± 0.8, *n* = 17; YC3.60, 1.1 ± 0.3, *n* = 11; YC-Nano15, 3.3 ± 1.6, *n* = 12; GCaMP3, 1.0 ± 0.4, *n* = 8). Responses to single CSs were suprathreshold in 59% (*n* = 10 of 17) of YC2.60-expressing cells and 83% (*n* = 10 of 12) of YC-Nano15-expressing cells, but in none of YC3.60-expressing cells (*n* = 0 of 12) or GCaMP3-expressing cells (*n* = 0 of 8). YC2.60 and YC-Nano15 showed larger SNR than YC3.60 and GCaMP3 over the entire stimulus range tested, both displaying little sign of saturation. Half rise time values (Figure [3](#F3){ref-type="fig"}F) were not significantly different among GECIs (YC2.60, 356 ± 171 ms, *n* = 8; YC3.60, 300 ± 41 ms, *n* = 7; YC-Nano15, 299 ± 30 ms, *n* = 7; GCaMP3, 334 ± 61 ms, *n* = 4), whereas half decay time values (Figure [3](#F3){ref-type="fig"}G) of YC2.60 (1.26 ± 0.58 s, *n* = 8) and YC-Nano15 (1.74 ± 0.54 s, *n* = 7) were significantly larger than those of YC3.60 (0.25 ± 0.11 s, *n* = 7) and GCaMP3 (0.16 ± 0.07 s, *n* = 4).

![**Quantitative comparison of GECIs in cerebellar Purkinje cells**. **(A)** Maximum intensity projection image (Venus emission) of an E12:P56 YC2.60-expressing Purkinje cell (left), and an expanded single *z*-section image within the blue box (right). Line-scan imaging was performed along the distal dendrite as indicated by the red line. Rec, an eletrode for patch-clamp recording; stim, an electrode for extracellular stimulation. **(B)** Smoothed ΔR/R~0~ traces of YC2.60 in response to a single complex spike (CS) for individual trials (gray) and the mean across trials (black). **(C)** ΔR/R~0~ (YC) or ΔF/F~0~ (GC3) traces in response to 1 (black), 2 (blue), 5 (green), 10 (red) CSs evoked at 10 Hz. Each trace is the mean across cells (*n* = 8 cells for YC2.60, 7 for YC3.60, 7 for YC-Nano15, and 8 for GCaMP3). **(D)** SNR plotted against the number of CSs, calculated for individual Purkinje cells (gray) and the mean across cells (black). For 1 CS, *n* = 17 for YC2.60, *n* = 11 for YC3.60, *n* = 12 for YC-Nano15, and *n* = 8 for GCaMP3; for 2, 5, and 10 CS, *n* = 8 for YC2.60, *n* = 7 for YC3.60, *n* = 7 for YC-Nano15, and *n* = 8 for GCaMP3. **(E)** SNR in response to single CSs taken from **(D)**. Each dot represents a value taken from an individual cell, and the bar represents the mean across cells. **(F,G)** Mean half rise time **(F)** and mean half decay time **(G)** of trial-averaged traces in response to 5 CSs at 10 Hz. Error bars show SD. \**p* \< 0.05, \*\**p* \< 0.01 in Tukey's post-hoc test following one-way ANOVA.](fncel-05-00018-g003){#F3}

###### 

**Electrophysiological properties of cerebellar Purkinje cells expressing GECIs**.

  Electrophysiological property   YC2.60 (*n* = 18)   YC3.60 (*n* = 11)   YC-Nano15 (*n* = 12)   GCaMP3 (*n* = 8)   no expression (*n* = 11)   *p*-value     
  ------------------------------- ------------------- ------------------- ---------------------- ------------------ -------------------------- ------------- ------
  *V*~m~^a^                       (mV)                −79 ± 6.5           −80 ± 3.7              −77 ± 7.6          −79 ± 4.8                  −79 ± 9.7     0.76
  *R*~m~^b^                       (MΩ)                40 ± 30             38 ± 32                37 ± 17            36 ± 11                    44 ± 18       0.95
  AP amplitude^c^                 (mV)                75 ± 7.3            74 ± 8.7               74 ± 5.9           70 ± 12                    74 ± 9.1      0.69
  AP threshold^d^                 (mV)                −52 ± 6.3           −55 ± 6.0              −53 ± 5.2          −54 ± 3.9                  −56 ± 7.7     0.50
  AP half width^e^                (ms)                0.42 ± 0.11         0.37 ± 0.09            0.43 ± 0.18        0.39 ± 0.11                0.40 ± 0.07   0.79

*Data presented as in Table [1](#T1){ref-type="table"}*.

###### 

**Responses of GECIs in cerebellar Purkinje cells**.

  Number of complex spikes   YC2.60 (A; *n* = 8)    YC3.60 (B; *n* = 7)     YC-Nano15 (C; *n* = 7)   GCaMP3 (D; *n* = 8)     ANOVA for SNR
  -------------------------- ---------------------- ----------------------- ------------------------ ----------------------- --------------------------------------
  1                          2.3 ± 0.8 (18 ± 8.2)   1.1 ± 0.3 (6.8 ± 2.6)   3.3 ± 1.6 (17 ± 7.7)     1.0 ± 0.4 (3.2 ± 1.7)   *p* \< 0.0001 / A \> B, D; C \> B, D
  2                          4.2 ± 2.2 (34 ± 20)    2.1 ± 0.4 (9.4 ± 2.8)   6.5 ± 2.6 (33 ± 14)      1.3 ± 0.9 (4.0 ± 3.3)   *p* \< 0.0001 / A \> D; C \> B, D
  5                          9.8 ± 5.6 (75 ± 43)    3.8 ± 1.7 (17 ± 8.2)    15 ± 7.3 (70 ± 27)       3.3 ± 4.2 (12 ± 18)     *p* = 0.0006 / C \> B, D
  10                         14 ± 9.1 (111 ± 63)    5.5 ± 3.6 (25 ± 16)     21 ± 12 (102 ± 39)       6.2 ± 9.2 (23 ± 39)     *p* = 0.0086 / C \> B, D

*Data presented as in Table [2](#T2){ref-type="table"}. The numbers of recorded cells in the table apply to 2, 5, and 10 CSs; for 1 CS, *n* = 17 for YC2.60, *n* = 11 for YC3.60, *n* = 12 for YC-Nano15, and *n* = 8 for GCaMP3*.

These results show that YC2.60 and YC-Nano15 are suitable for detecting CSs in cerebellar Purkinje cells despite the slow decay kinetics.

The stability of GECI expression and responses
----------------------------------------------

One of the major advantages of GECIs over synthetic Ca^2+^ dyes should be its stable expression over time, allowing its application to tracking long-term plasticity of neuronal activity. It was previously demonstrated that the performance of GECIs could remain stable for weeks to months after expression in cortical pyramidal cells (Mank et al., [@B26]; Tian et al., [@B47]; Horikawa et al., [@B16]). To test if this is also the case in Purkinje cells, we prepared acute cerebellar slices from YC2.60-expressing mice older than P100. The expression of YC2.60 was stable (Figure [4](#F4){ref-type="fig"}A), and its responses to a train of CSs were not significantly different from those in younger animals (P22--56; Figures [4](#F4){ref-type="fig"}B,C; Table [5](#T5){ref-type="table"}; unpaired Student's *t*-test). These results confirm the idea that GECIs can be promising tools for chronic recording of neuronal activity.

![**Stability of YC2.60 expression and responses**. **(A)** Maximum intensity projection image (Venus emission) of an E12:P113 YC2.60-expressing Purkinje cell. **(B)** ΔR/R~0~ traces in response to 1 (black), 2 (blue), 5 (green), 10 (red) CSs evoked at 10 Hz, recorded from YC2.60-expressing Purkinje cells at P113--114. Each trace is the mean across cells (*n* = 5). **(C)** SNR plotted against the number of CSs, calculated for individual Purkinje cells (gray) and the mean across cells (black, *n* = 5).](fncel-05-00018-g004){#F4}

###### 

**Responses of YC2.60 in cerebellar Purkinje cells from older mice**.

  Number of complex spikes   SNR \[Peak amplitude (%)\]   Student's *t*-test for SNR
  -------------------------- ---------------------------- ----------------------------
  1                          2.5 ± 0.7 (13 ± 4.7)         *p* = 0.75
  2                          4.1 ± 0.9 (23 ± 7.9)         *p* = 0.89
  5                          9.8 ± 3.6 (58 ± 27)          *p* = 0.98
  10                         18 ± 8.8 (109 ± 60)          *p* = 0.48

*Data presented as in Table [2](#T2){ref-type="table"}. SNR of YC2.60 in Purkinje cells from older mice (P113--114; *n* = 5) was compared with that from younger mice (P22--56; see Table [4](#T4){ref-type="table"}) by unpaired two-tailed Student's *t*-test in each stimulus condition*.

Discussion
==========

We tested the performance of YC2.60, YC3.60, YC-Nano15, and GCaMP3 in mouse cortical pyramidal cells and cerebellar Purkinje cells. Our results suggest that (1) YC2.60 would be suitable for reliable detection of sparse firing of APs in cortical pyramidal cells; (2) GCaMP3 would be suitable for detecting burst firing of APs in pyramidal cells; and (3) YC2.60 as well as YC-Nano15 would be suitable for detecting CSs in cerebellar Purkinje cells. To our knowledge, this is the first study that quantitatively compares the performance of multiple GECIs in Purkinje cells, and thus should provide useful implications for the broader application of GECIs in mammalian CNS.

Comparison with previous studies using the same GECIs
-----------------------------------------------------

In the present study, we performed the first quantitative characterization of the performance of YC2.60 in multiple mammalian neurons, and found that it exhibits good performance with little sign of signal saturation both in cortical pyramidal cells and cerebellar Purkinje cells.

In our previous work, YC-Nano15 showed much higher affinity than YC2.60 in Ca^2+^ titration experiment using purified proteins (*K*~d~ of YC-Nano15, 15 nM; *K*~d~ of YC2.60, 95 nM; Horikawa et al., [@B16]). In the present study, we found (1) in pyramidal cells YC2.60 was as sensitive to single APs as YC-Nano15 and showed better responses to larger number of APs without signal saturation and (2) in Purkinje cells they showed comparable responses, YC-Nano15 showing slightly (but not significantly) better SNR over the entire stimulus range tested (1--10 CSs at 10 Hz). The fact that YC-Nano15 was still responsive to stimulation without being saturated by the resting \[Ca^2+^\]~i~ (\~53 nM in cortical pyramidal cells (Schiller et al., [@B42]) and \~67 nM in Purkinje cells (Konnerth et al., [@B21]) implies that its affinity may decrease when expressed in neurons (see Hendel et al., [@B13]). YC-Nano15 still seems to have a higher affinity than YC2.60 in cortical pyramidal cells, whereas there seems to be little difference between YC-Nano15 and YC2.60 in Purkinje cells. This inconsistency between the two cell types will be discussed in the next section.

The relatively low reliability of single AP detection with YC3.60 and GCaMP3 in cortical L2/3 pyramidal cells contrasts with previous *in vitro* results (Tian et al., [@B47]; Lütcke et al., [@B23]), but is reminiscent of *in vivo* results in the same studies. This could be explained in part by the difference in the recording temperatures: \~33°C in our study vs. room temperature (22--24°C) for their *in vitro* experiments. Higher temperature should make Ca^2+^ transients smaller and faster, probably due to more active Ca^2+^ extrusion mechanisms and narrower APs (Markram et al., [@B29]). These factors should in turn decrease responses of GECIs, as predicted and demonstrated by the same group (Hires et al., [@B15]; Mao et al., [@B27]). Indeed, we also found that SNR of GCaMP3 in response to single APs was larger at room temperature (2.2 ± 0.4, *n* = 4) than at 31--35°C (1.3 ± 0.6, *n* = 7; *p* \< 0.05, unpaired two-tailed Student's *t*-test). Taken together, our results underscore the importance of appropriately designed *in vitro* experiments for accurate estimation of GECI performance *in vivo*.

Difference in GECI performance between pyramidal cells and Purkinje cells
-------------------------------------------------------------------------

Previous studies using synthetic Ca^2+^ dyes show that Ca^2+^ transients generated by single APs in cortical pyramidal cells (262 ± 25 nM, Helmchen et al., [@B12]) and those by single CSs in Purkinje cells (\~150 nM, Wang et al., [@B49]) are comparable *in vitro*, and that both are detectable *in vivo* with comparably high fidelity (up to \~97% for L2/3 pyramidal cells (Kerr et al., [@B19]) and \~95% for Purkinje cells (Ozden et al., [@B37]). However, all the tested GECIs had a tendency to show remarkably smaller responses in Purkinje cells than in pyramidal cells, as is evident from the smaller SNR (for instance, SNR of YC2.60 in response to single pulse of stimulation were 4.3 ± 1.7 in pyramidal cells and 2.3 ± 0.8 in Purkinje cells, respectively) and the smaller percentage of cells with suprathreshold responses (for instance, YC2.60 showed suprathreshold responses to single pulse of stimulation in 89% of pyramidal cells and 59% of Purkinje cells, respectively). The mechanism responsible for this strikingly different performance of GECIs in these two cell types is unclear, but it may be accounted for, at least in part, by the much higher endogenous Ca^2+^ buffering capacity in Purkinje cells (Fierro and Llano, [@B7]; Helmchen et al., [@B12]; Maeda et al., [@B24]), which presumably reflects the total activity of Ca^2+^-binding proteins. We speculate that a larger amount of Ca^2+^-binding proteins expressed in Purkinje cells might have decreased the performance of all the GECIs tested and also somehow masked the difference between YC2.60 and YC-Nano15. In line with the notion above that GECI performance could be dramatically altered in different cell types expressing different amount of Ca^2+^-binding proteins, it was previously reported that the performance of YCs containing wild type CaM could be interfered with CaM in a concentration-dependent manner (Miyawaki et al., [@B33]; Palmer et al., [@B39], [@B38]).

Implications for future improvement and application of GECIs
------------------------------------------------------------

YC2.60 and YC-Nano15 reliably responded to single APs and CSs, but their decay kinetics were slow, which could be a disadvantage for detecting individual events at frequency higher than 1 Hz (Horikawa et al., [@B16]). In contrast, YC3.60 and GCaMP3 showed faster signal decay, but they did not reliably detect small numbers of spikes. Resolving this tradeoff between sensitivity and on/off kinetics should be the focus of future improvement or development of GECIs.

Nevertheless, YC2.60 and YC-Nano15 might be fast enough for detecting spontaneous AP firing of cortical L2/3 pyramidal cells as well as spontaneous CS firing of Purkinje cells *in vivo*, which are both known to occur at relatively low frequency, typically 1 Hz or less (Thach, [@B46]; Margrie et al., [@B28]). It would thus be interesting to apply these GECIs to monitoring long-term plasticity of spontaneous activity in the context of learning, development and disease.
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